Workflow Orchestration for Pharmacovigilance in Retail

Data Characteristics in This Domain

Pharmacovigilance data in retail pharmacy chains originates from sales systems, customer feedback channels, and pharmacist reporting systems. Data updates frequently, typically in real-time or daily, reflecting the latest drug sales and adverse event information. Document structures vary, including sales records (containing drug batch numbers, manufacturing dates, expiration dates), customer inquiry records (free-text format), and pharmacist-submitted suspected adverse reaction reports (structured forms with patient information, drug details, event descriptions, and actions taken). Fields include common drug names, brand names, specifications, and manufacturers, along with store codes, sales times, anonymized purchaser contact information, and adverse reaction severity classifications (e.g., "mild," "moderate," "severe"). Units for drug dosages are often in milligrams (mg), grams (g), or milliliters (ml). Report times are recorded with specific dates and timestamps.

Constraints Imposed by These Characteristics on Workflow Orchestration

The high frequency of data updates in retail pharmacy chains requires workflows to support real-time or near real-time event triggering and processing, preventing information delays. Diverse data sources (structured and unstructured) challenge data preprocessing, requiring flexible parsing components to extract key information. For example, workflows need to identify drug names and adverse symptoms from free-text customer inquiries or link batch information from sales records. The inclusion of store codes and sales times demands more refined filtering and matching logic for event tracing and attribution analysis. Furthermore, the severity classification of adverse reaction reports directly influences subsequent risk assessment and reporting process branches, requiring workflows to have conditional logic for differentiated handling. Anonymization of sensitive information must occur early in the workflow to prevent privacy breaches.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`triggerInterval`	`300 seconds`	Retail chains have fast data updates; a shorter interval ensures timely response to new events.
`maxContext`	`3000 characters`	Customer inquiries and adverse reaction descriptions can be long; this ensures full capture of key information.
`Chunk size`	`500 characters`	Balances RAG retrieval efficiency with content completeness, preventing loss of detail in overly long segments.
`Similarity threshold`	`0.75`	Improves recall precision, filtering out irrelevant pharmaceutical knowledge or historical cases.
`MCP_Service_Timeout`	`60 seconds`	External service calls, such as drug information queries or reporting system interfaces, may have longer response times. This allows sufficient time.
`maxRetries`	`3`	External interfaces or network fluctuations can be intermittent; retries enhance workflow robustness.

Common Mistakes

The model's dialogue component in the workflow fails to display the current date correctly. This happens when the built-in time variable is not referenced properly, resulting in a fixed or empty date.
Logs for a specific MCP service component are not visible during workflow debugging. The log window is blank or shows a LOG_FETCH_FAILED error. This usually indicates that the log level is set too low or enable_logging is not enabled in the component's configuration.
The same task executes slower in the workflow than in a direct chat window, showing significantly longer processing times. This may be due to unnecessary intermediate steps or repeated calls to computationally intensive components within the workflow.

Verification Steps

After triggering the workflow, check if the triggerTime field in the logs matches the actual data update time. This confirms real-time performance.
Run the workflow with simulated customer inquiry text. Check if the final output's drug name and symptom fields are completely and accurately extracted, comparing them against manual assessment.
Use a virtual patient report containing sensitive information. Run the workflow and check the intermediate step outputs and the final report to ensure patient names, contact information, and other fields are anonymized as configured, complying with privacy requirements.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.